Issue 1/2020
Content (27 Articles)
Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis
William J. Gibson, Tarek Nafee, Ryan Travis, Megan Yee, Mathieu Kerneis, Magnus Ohman, C. Michael Gibson
Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial
Takenori Yamaguchi, Toshiaki Shirai, Satoshi Yoshiba, Kenji Abe, Yasuo Ikeda
Determinants of anticoagulant therapy in atrial fibrillation at discharge from a geriatric ward: cross sectional study
Z. B. Wojszel, A. Kasiukiewicz
Comparison of polyspecific versus IgG specific ELISA in predominately cardiac patients with suspected heparin induced thrombocytopenia
Sophie Samuel, Mary F. McGuire, Jennifer Cortes, Miguel Escobar, Phillip Weeks, Andy Nguyen
Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team
Yu Lin Chen, Colin Wright, Anthony P. Pietropaoli, Ayman Elbadawi, Joseph Delehanty, Bryan Barrus, Igor Gosev, David Trawick, Dhwani Patel, Scott J. Cameron
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study
Vincenzo Russo, Emilio Attena, Marco Di Maio, Carmine Mazzone, Andreina Carbone, Valentina Parisi, Anna Rago, Antonio D’Onofrio, Paolo Golino, Gerardo Nigro
Pulmonary embolism response team implementation improves awareness and education among the house staff and faculty
Yevgeniy Brailovsky, Siri Kunchakarra, Vladimir Lakhter, Geoffrey Barnes, Dalila Masic, Erin Mancl, Katerina Porcaro, Carlos F. Bechara, John J. Lopez, Kevin Simpson, Verghese Mathew, Jawed Fareed, Amir Darki
Cancer-associated thromboembolism: antithrombotic management of hospitalized patients
Larry K. Golightly, Bonita A. Simendinger, Tyree H. Kiser
ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis
Anne-Sophie Putzer, Hans Worthmann, Gerrit M. Grosse, Friedrich Goetz, Jens Martens-Lobenhoffer, Meike Dirks, Jan T. Kielstein, Ralf Lichtinghagen, Ulrich Budde, Stefanie M. Bode-Böger, Karin Weissenborn, Ramona Schuppner
Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice
Elisa Grifoni, Davide Giglio, Giulia Guazzini, Eleonora Cosentino, Ester Latini, Alessandro Dei, Attilio Del Rosso, Vincenzo Guarnaccia, Mariella Baldini, Maria Letizia Bartolozzi, Pietro Martinucci, Francesca Sani, Antonio Giordano, Francesca Dainelli, Francesca Maggi, Chiara Giulietti, Mario Romagnoli, Stefano Cinotti, Elena Schipani, Giuseppe Salvatore Murgida, Stefania Di Martino, Andrea Cozzi, Adele Carli Ballola, Debora Dacomo, Debora Valori, Luca Masotti
Management of oral anticoagulation in very old patients with non valvular atrial fibrillation related acute ischemic stroke
Vieri Vannucchi, Federico Moroni, Elisa Grifoni, Rossella Marcucci, Giancarlo Landini, Domenico Prisco, Luca Masotti
Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis
Yoshiyuki Morishima, Chikako Kamisato, Yuko Honda
Appropriateness of thrombophilia testing in patients in the acute care setting and an evaluation of the associated costs
Riddhi Virparia, Luigi Brunetti, Stuart Vigdor, Christopher D. Adams
Universal venous thromboembolism policy is effective but may not adequately protect hospitalized cancer patients with larger BMI
Anna Xu, Hassan Sibai, Eshetu G. Atenafu, Kelsey Japs, Jack T. Seki
Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
Jennifer A. Frontera, Prachi Bhatt, Rebecca Lalchan, Shadi Yaghi, Tania Ahuja, John Papadopoulos, Danielle Joset
“Minor” stroke: not a minor, still open question
Eugenia Rota, Nicola Morelli, Paolo Immovilli, Davide Cerasti, Andrea Zini, Donata Guidetti
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.
Antonella Mameli, Paola Schirru, Mariagrazia Porru, Francesco Marongiu, Doris Barcellona
Life after abciximab; what’s next for intracoronary thrombus?
D. McGhie, D. Amos, A. Elder, D. Brieger, H. C. Lowe
An unusual cause of acute ischemic stroke: Adult Onset Still’s Disease
Yihui Goh, Venetia Yunjia Wong, Wei Lin Tan, Benjamin Yong-Qiang Tan, Hock Luen Teoh
Ticagrelor and tirofiban in pregnancy and delivery: beyond labels
Donatella Argentiero, Stefano Savonitto, Paola D’Andrea, Fortunato Iacovelli
Warfarin induced leukocytoclastic vasculitis: an extraordinary side effect
Dina Elantably, Ahmed Mourad, Ahmed Elantably, Mohamed Effat
Prolonged activated partial thromboplastin time after prophylactic-dose unfractionated heparin in the post-operative neurosurgical setting: case series and management recommendations
Michael Shusterman, Niklas Grassl, Karen Berger, Maria T. De Sancho
A case of acute pancreatitis-induced microangiopathic hemolytic anemia with thrombocytopenia
Kevin M. Hill, Danielle Moorman, Jonathan Mack, Carol Gonsalves, Roy Khalife
Platelet reactivity in patients with chronic kidney disease and hemodialysis
Philipp Mourikis, Carolin Helten, Lisa Dannenberg, Thomas Hohlfeld, Johannes Stegbauer, Tobias Petzold, Bodo Levkau, Tobias Zeus, Malte Kelm, Amin Polzin
Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint
Bernhard Wernly, Richard Rezar, Paul Gurbel, Christian Jung